KARYOPHARM THERAPEUTICS INC. (KPTI)
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Karyopharm Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
WF International Limited Announces Share Consolidation
AAR announces participation in 2026 William Blair Growth Stock Conference
Resmed Completes Acquisition of Noctrix Health, Expanding Clinical Sleep Health Portfolio
HONEYWELL APPOINTS JILL EVANKO TO BOARD OF DIRECTORS
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Abivax Announces Landmark Phase 3 ABTECT Maintenance Trial Results Evaluating Obefazimod in Moderately to Severely Active Ulcerative Colitis
Heidmar Maritime Holdings Corp. Announces Transition in Chief Financial Officer Role
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
New Jersey Natural Gas Submits Filings to NJBPU for Customer Savings and Future Recovery of Reliability Investments